Type | Public | |
Founded | 1949 | |
HQ | Dublin, IE | Map |
Website | medtronic.com | |
Employee Ratings | ||
Overall Culture | B+ | More |
Medtronic has offices in Dublin, Boulder, Columbia Heights, Doral and in 76 other locations
Medtronic's revenue was reported to be $31.69 b in FY, 2022
USD
Revenue (FY, 2022) | $31.69 b |
Gross profit (FY, 2022) | $22.52 b |
Net income (FY, 2022) | $5.06 b |
EBITDA (FY, 2022) | $8.54 b |
EBIT (FY, 2022) | $6.12 b |
Market capitalization (01-Jul-2022) | $121.42 b |
Closing stock price(01-Jul-2022) | $91.38 |
Cash (29-Apr-2022) | $3.71 b |
EV | $141.82 b |
Medtronic's current market capitalization is $121.4 b.
USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
---|---|---|---|---|---|
Revenue | 30 b | 30.6 b | 28.9 b | 30.1 b | 31.7 b |
Cost of goods sold | (8.2 b) | (8.3 b) | (8.5 b) | (9.6 b) | (9.2 b) |
Gross profit | 22.4 b | 22.3 b | 20.4 b | 20.6 b | 22.5 b |
R&D expense | (2.3 b) | (2.3 b) | (2.3 b) | (2.5 b) | (2.7 b) |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.4 b | 7.5 b | 7.5 b | 7.5 b | 7.7 b | 7.7 b | 6.5 b | 7.6 b | 7.8 b | 8 b | 7.8 b | 7.8 b |
Cost of goods sold | (1.5 b) | (2.4 b) | (1.1 b) | (2.1 b) | (2.2 b) | (2.2 b) | (2.3 b) | (2.5 b) | (2.4 b) | (2.4 b) | (2.3 b) | (1.8 b) |
Gross profit | 5.8 b | 5 b | 6.4 b | 5.4 b | 5.5 b | 5.5 b | 4.3 b | 5.1 b | 5.4 b | 5.6 b | 5.6 b | 6 b |
R&D expense | (585 m) | (590 m) | (561 m) | (587 m) | (603 m) | (573 m) | (621 m) | (639 m) | (601 m) | (750 m) | (676 m) | (668 m) |
USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
---|---|---|---|---|---|
Cash | 3.7 b | 4.4 b | 4.1 b | 3.6 b | 3.7 b |
Accounts Receivable | 6 b | 6.2 b | 4.6 b | 5.5 b | 5.6 b |
Prepaid Expenses | 0 | 0 | 0 | 0 | 0 |
Inventories | 3.6 b | 3.8 b | 4.2 b | 4.3 b | 4.6 b |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 4.4 b | 3.9 b | 3.7 b | 5.1 b | 4 b | 3.7 b | 6.5 b | 6.4 b | 5.1 b | 3 b | 2.9 b | 3.5 b |
Accounts Receivable | 5.7 b | 5.7 b | 5.9 b | 5.9 b | 6.1 b | 6.2 b | 4.9 b | 5.3 b | 5.2 b | 5.4 b | 5.5 b | 5.4 b |
Prepaid Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 3.7 b | 3.8 b | 3.9 b | 3.9 b | 4 b | 4.1 b | 4.6 b | 4.5 b | 4.5 b | 4.3 b | 4.3 b | 4.5 b |
USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
---|---|---|---|---|---|
Net Income | 3.1 b | 4.7 b | 4.8 b | 3.6 b | 5.1 b |
Depreciation and Amortization | 2.6 b | 2.7 b | 2.7 b | 2.7 b | 2.7 b |
Accounts Receivable | (275 m) | (581 m) | 1.3 b | (761 m) | (477 m) |
Inventories | (192 m) | (274 m) | (577 m) | 78 m | (560 m) |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 | Q1, 2022 | Q2, 2022 | Q3, 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 1.1 b | 2.2 b | 3.5 b | 877 m | 2.2 b | 4.2 b | 491 m | 985 m | 2.3 b | 769 m | 2.1 b | 3.6 b |
Depreciation and Amortization | 666 m | 1.3 b | 2 b | 657 m | 1.3 b | 2 b | 669 m | 1.3 b | 2 b | 671 m | 1.3 b | 2 b |
Accounts Receivable | 138 m | (37 m) | (140 m) | 319 m | 39 m | (119 m) | (142 m) | (669 m) | (450 m) | (40 m) | (171 m) | (212 m) |
Inventories | (180 m) | (312 m) | (367 m) | (122 m) | (267 m) | (346 m) | (235 m) | (145 m) | (75 m) | (75 m) | (156 m) | (359 m) |
EV/EBITDA | 19.2 x |
EV/EBIT | 26.7 x |
EV/CFO | 22.3 x |
Revenue/Employee | 333.5 k |
Medtronic revenue breakdown by business segment: 7.4% from DIABETES GROUP, 28.8% from MEDICAL SURGICAL, 27.7% from NEUROSCIENCE and 36.1% from CARDIOVASCULAR
Medtronic revenue breakdown by geographic segment: 100.0% from IRELAND
Medtronic's Floor Space, square feet was reported to be 9.6 m in FY, 2021.
Company Name | Date | Deal Size |
---|---|---|
Affera | January 10, 2022 | $925 m |
Intersect ENT | August 06, 2021 | $1.1 b |
Ai Biomed | October 29, 2020 | |
Companion Medical | August 11, 2020 | |
Medicrea | July 15, 2020 | |
Digital Surgery | February 13, 2020 | |
Stimgenics | January 08, 2020 | |
Klue | December 17, 2019 | |
AV Medical | October 11, 2019 | $30 m |
Titan Spine | May 10, 2019 |
Source: www.medtronic.com, www.medtronic.com, www.medtronic.com, europe.medtronic.com
Source: 9 public H-1B filings from Medtronic
5.32 k
Tweets
395
Following
82.82 k
Followers
29
Tweets last 30 days
6.7
Avg. likes per Tweet
65.5%
Tweets with engagement
45 products used
60 products used
20 products used
4 products used
B+
74/100
A+
80/100
A-
77/100
B
71/100
Receive alerts for 300+ data fields across thousands of companies